Bank of New York Mellon
GHSI

Bank of New York Mellon’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Bank of New York Mellon’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-135
Closed -$17K – 4374
2020
Q4 		$17K Hold
135
– – ﹤0.01% 4196
2020
Q3 		$8K Hold
135
– – ﹤0.01% 4107
2020
Q2 		$18K Sell
135
-135
-50% -$18.8K ﹤0.01% 4059
2020
Q1 		$37K Buy
+270
New +$28.6K ﹤0.01% 4006

Other funds holding GHSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Bank of New York Mellon's GHSI Position: Q1 2021 in Review

Bank of New York Mellon sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q1 2021, closing a stake of 135 shares — an estimated $17K sold.

Bank of New York Mellon first reported a position in GHSI in Q1 2020 and held it in 4 quarters. The position peaked at $37K in Q1 2020. 14 funds tracked by Wall St. Rank hold GHSI as of Q1 2021.

  • Bank of New York Mellon reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 135 Guardion Health Sciences, Inc. Common Stock shares in Q1 2021, an estimated $17K.
  • Bank of New York Mellon first reported a position in Guardion Health Sciences, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Bank of New York Mellon's Guardion Health Sciences, Inc. Common Stock position peaked at $37K in Q1 2020.
  • 14 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q1 2021.

Based on Bank of New York Mellon's 13F filing for Q1 2021, filed 13 May 2021.